GOLIMUMAB SIGNIFICANTLY IMPROVES SELF-REPORTED PRODUCTIVITY IN PATIENTS WITH RHEUMATOID ARTHRITIS

GOLIMUMAB SIGNIFICANTLY IMPROVES SELF-REPORTED PRODUCTIVITY IN PATIENTS WITH RHEUMATOID ARTHRITIS

Bibliographic Details
Main Authors:	Wordsworth, P, Buchanan, J, Fleischmann, R, Genovese, M, Kay, J, Hsia, E, Doyle, M, Rahman, M, Han, C, Parasuraman, S
Format:	Conference item
Published:	2009

Similar Items

GOLIMUMAB, A HUMAN TNF-ALPHA mu ONOCLONAL ANTIBODY, IN RHEUMATOID ARTHRITIS PATIENTS PREVIOUSLY TREATED WITH ANTI-TNF-ALPHA AGENTS (GO-AFTER STUDY)
by: Wordsworth, P, et al.
Published: (2009)

THE EFFECT OF GOLIMUMAB ON ARTERIAL STIFFNESS IN PATIENTS WITH RHEUMATOID ARTHRITIS
by: L. A. Knyazeva, et al.
Published: (2018-03-01)

Why golimumab in the treatment of psoriatic arthritis, ankylosing spondylitis and rheumatoid arthritis?
by: M. Rossini, et al.
Published: (2015-03-01)

GOLIMUMAB SIGNIFICANTLY IMPROVES PHYSICAL FUNCTION AND FATIGUE IN RA PATIENTS PREVIOUSLY TREATED WITH ANTI-TNF AGENTS: RESULTS FROM THE GO-AFTER STUDY
by: Kay, J, et al.
Published: (2010)

Maintenance of efficacy and safety with subcutaneous golimumab among patients with active rheumatoid arthritis who previously received intravenous golimumab.
by: Taylor, P, et al.
Published: (2011)

Long-term effectiveness and safety of infliximab, golimumab and golimumab-IV in rheumatoid arthritis patients from a Canadian prospective observational registry
by: Proton Rahman, et al.
Published: (2020-09-01)

Golimumab for the treatment of psoriatic arthritis
by: H Yang, et al.
Published: (2011-05-01)

The tumor necrosis factor-α inhibitor golimumab in the treatment of rheumatoid arthritis
by: Natalia Vladimirovna Chichasova
Published: (2014-12-01)

Pooled safety results across phase 3 randomized trials of intravenous golimumab in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis
by: M. Elaine Husni, et al.
Published: (2022-03-01)

Long-term results of golimumab therapy for rheumatoid arthritis. Therapy compliance issues
by: N. V. Chichasova
Published: (2016-06-01)

Efficacy and safety of intravenous golimumab plus methotrexate in patients with rheumatoid arthritis aged < 65 years and those ≥ 65 years of age
by: John Tesser, et al.
Published: (2019-08-01)

EFFECT OF GOLIMUMAB ON IMMUNOLOGICAL MARKERS FOR BONE METABOLISM AND ON ARTERIAL STIFFNESS IN PATIENTS WITH RHEUMATOID ARTHRITIS
by: L. A. Knyazeva, et al.
Published: (2018-07-01)

GOLIMUMAB IS EFFICACIOUS IN ANTI-TNF EXPERIENCED PTS WITH ACTIVE RA REGARDLESS OF TYPE OF AGENT OR REASON FOR DISCONTINUATION OF PRIOR ANTI-TNF: GO-AFTER STUDY
by: Smolen, J, et al.
Published: (2010)

Golimumab in the treatment of psoriatic arthritis: efficacy and safety
by: Tatiana Viktorovna Korotaeva, et al.
Published: (2015-09-01)

Persistence and Safety of Golimumab in Elderly Patients with Rheumatoid Arthritis and Renal Dysfunction in a Real-World Setting
by: Seiji Yokoyama, et al.
Published: (2022-11-01)

Successful adalimumab graded challenge after allergic delayed reaction to golimumab in a woman with rheumatoid arthritis
by: Federica Rivolta, et al.
Published: (2023-03-01)

Dose Adjustment of Methotrexate Administered Concomitantly with Golimumab for Rheumatoid Arthritis in Japanese Real-World Clinical Settings
by: Fumiko Yamairi, et al.
Published: (2020-08-01)

Effectiveness and safety of intravenous golimumab with and without concomitant methotrexate in patients with rheumatoid arthritis in the prospective, noninterventional AWARE study
by: Aaron Broadwell, et al.
Published: (2023-03-01)

Two-year clinical outcomes after discontinuation of long-term golimumab therapy in Korean patients with rheumatoid arthritis
by: Kichul Shin, et al.
Published: (2022-09-01)

Golimumab for Polyarticular Juvenile Idiopathic Arthritis and Psoriatic Arthritis: Pharmacologic and Clinical Considerations
by: Sydney Moore McIntosh, et al.
Published: (2023-07-01)

Golimumab in juvenile idiopathic arthritis-associated uveitis unresponsive to Adalimumab
by: Sofia Lanz, et al.
Published: (2021-08-01)

Effect of Golimumab Dose Escalation in Japanese Patients With Rheumatoid Arthritis: Post-Hoc Analysis of Post-Marketing Surveillance Data
by: Hirohito Shimizu, et al.
Published: (2020-02-01)

Rheumatoid arthritis.
by: Wordsworth, P
Published: (1992)

The immunogenetics of rheumatoid arthritis.
by: Wordsworth, B, et al.
Published: (1992)

A Real-World Claims Database Study Assessing Long-Term Persistence with Golimumab Treatment in Patients with Rheumatoid Arthritis in Japan
by: Masahiko Miyashiro, et al.
Published: (2023-02-01)

Correction to: Effect of Golimumab Dose Escalation in Japanese Patients With Rheumatoid Arthritis: Post-Hoc Analysis of Post-Marketing Surveillance Data
by: Hirohito Shimizu, et al.
Published: (2020-10-01)

Role of golimumab, a TNF-alpha inhibitor, in the treatment of the psoriatic arthritis
by: Melissa A Michelon, et al.
Published: (2010-05-01)

The immunogenetics of rheumatoid arthritis.
by: Wordsworth, P
Published: (1990)

Golimumab in the treatment of ulcerative colitis
by: Georgina Cunningham, et al.
Published: (2019-01-01)

Polygenic susceptibility in rheumatoid arthritis.
by: Wordsworth, B, et al.
Published: (1991)

Golimumab for the treatment of ulcerative colitis
by: Löwenberg M, et al.
Published: (2014-03-01)

Response to Treatment with Intravenous Golimumab or Infliximab in Rheumatoid Arthritis Patients: PROMIS Results from the Real-World Observational Phase 4 AWARE Study
by: Clifton O. Bingham, et al.
Published: (2023-02-01)

Molecular genetics of rheumatoid arthritis.
by: Harney, S, et al.
Published: (2003)

Progress in the immunogenetics of rheumatoid arthritis.
by: Wordsworth, P
Published: (1995)

Golimumab therapy-induced indicators of X-ray inflammation progression and magnitude according to magnetic resonance imaging evidence in patients with rheumatoid arthritis, ankylosing spondylitis, or psoriatic arthritis
by: Aleksandr Viktorovich Smirnov
Published: (2013-06-01)

Genetic epidemiology of rheumatoid arthritis.
by: Harney, S, et al.
Published: (2002)

A review of the MHC genetics of rheumatoid arthritis.
by: Newton, J, et al.
Published: (2004)

Comparative analysis of US real-world dosing patterns and direct infusion-related costs for matched cohorts of rheumatoid arthritis patients treated with infliximab or intravenous golimumab
by: Ellis LA, et al.
Published: (2019-01-01)

Golimumab Therapy in Ulcerative Colitis
by: Won Moon
Published: (2016-02-01)

T cell genetics and rheumatoid arthritis (RA)
by: Wordsworth, P
Published: (1998)